June 2011: NAARI signs licensing agreement for fourth generation OC

June 2, 2011

NAARI signs licensing agreement for fourth generation oral contraceptive (OC), Dienogest 2mg + Ethinyl Estradiol 0.03 mg tab with a Spanish firm for emerging markets like Asia-Pacific region, Kazakhstan, Ukraine and other CIS countries, strengthening its presence in these countries. It will hold the marketing and distribution rights for the product in these countries.